Compounds > trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride
Page last updated: 2024-08-21

trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride and HIV Coinfection

trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achour, A2

Other Studies

2 other study(ies) available for trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride and HIV Coinfection

ArticleYear
Increased beta-chemokine production in peripheral blood mononuclear cells derived from HIV-1-infected individuals by a cationic amphiphilic drug (AY 9944) in vitro.
    AIDS (London, England), 2000, Jul-07, Volume: 14, Issue:10

    Topics: Adjuvants, Immunologic; Chemokine CCL4; Chemokine CCL5; Chemokines, CC; HIV Infections; HIV-1; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Macrophage Inflammatory Proteins; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride

2000
The cationic amphiphilic molecules as potential immunostimulants for HIV-1 infection.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:3

    Topics: Adjuvants, Immunologic; HIV Infections; Humans; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride

2001